. . "E Narvestad" . . "CIMESTRA study group" . . "MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial"@nl . . . . "O Majgaard" . . "article scientifique publi\u00E9 en 2008"@fr . . . . "J Vall\u00F8" . . "A Vestergaard" . "P Junker" . . . "68" . . "B Ejbjerg" . . "T Lottenburger" . "art\u00EDculu cient\u00EDficu espubliz\u00E1u n'abril de 2008"@ast . . . . "wetenschappelijk artikel"@nl . . . "MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)"@en . . . "MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial"@nl . . . . "384-390" . . . . . "L S Andersen" . "T Torfing" . . . "scientific article published on 03 April 2008"@en . . . "MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)"@en . . . "10.1136/ARD.2008.088245" . "18388160" . "A G Jurik" . "U Tarp" . "K Stengaard-Pedersen" . "im M\u00E4rz 2009 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . "3" . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0431\u0435\u0440\u0435\u0437\u043D\u0456 2009"@uk . "H S Thomsen" . . . . "M Ostergaard" . . "MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial"@nl . . "MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)"@en . . . "2008-04-03T00:00:00Z"^^ . "A F Christensen" . . . . "I Hansen" . "H Skj\u00F8dt" . "MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)"@en . . . . . .